Glecaprevir / pibrentasvir

# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider.  WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery.  The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements.  WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

# Black Box Warning

# Overview
Glecaprevir / pibrentasvir is a Acetylcholine release inhibitor, Adrenergic receptor agonist that is FDA approved for the {{{indicationType}}} of a list of indications, separated by commas.. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include a list of adverse reactions, separated by commas..

# Adult Indications and Dosage

## FDA-Labeled Indications and Dosage (Adult)
- Dosing Information
- (Dosage)
- Dosing Information
- (Dosage)

## Off-Label Use and Dosage (Adult)

### Guideline-Supported Use
- Developed by: (Organisation)
- Class of Recommendation: (Class) (Link)
- Strength of Evidence: (Category A/B/C) (Link)
- Dosing Information/Recommendation
- (Dosage)
- Developed by: (Organisation)
- Class of Recommendation: (Class) (Link)
- Strength of Evidence: (Category A/B/C) (Link)
- Dosing Information/Recommendation
- (Dosage)

### NonGuideline-Supported Use
- Dosing Information
- (Dosage)
- Dosing Information
- (Dosage)
- Dosing Information
- (Dosage)

# Pediatric Indications and Dosage

## FDA-Labeled Indications and Dosage (Pediatric)
- Dosing Information
- (Dosage)
- Dosing Information
- (Dosage)

## Off-Label Use and Dosage (Pediatric)

### Guideline-Supported Use
- Developed by: (Organisation)
- Class of Recommendation: (Class) (Link)
- Strength of Evidence: (Category A/B/C) (Link)
- Dosing Information/Recommendation
- (Dosage)
- Developed by: (Organisation)
- Class of Recommendation: (Class) (Link)
- Strength of Evidence: (Category A/B/C) (Link)
- Dosing Information/Recommendation
- (Dosage)

### NonGuideline-Supported Use
- Dosing Information
- (Dosage)
- Dosing Information
- (Dosage)
- Dosing Information
- (Dosage)

# Contraindications
CONTRAINDICATIONS

# Warnings
(Description)
(Description)
(Description)

# Adverse Reactions

## Clinical Trials Experience

## Postmarketing Experience
(Description)

# Drug Interactions
- Drug 1
- Drug 2
- Drug 3
- Drug 4
- Drug 5
(Description)
(Description)
(Description)
(Description)
(Description)

# Use in Specific Populations

### Pregnancy
Pregnancy Category (FDA): 
(Description)
Pregnancy Category (AUS): 
(Description)

### Labor and Delivery
(Description)

### Nursing Mothers
(Description)

### Pediatric Use
(Description)

### Geriatic Use
(Description)

### Gender
(Description)

### Race
(Description)

### Renal Impairment
(Description)

### Hepatic Impairment
(Description)

### Females of Reproductive Potential and Males
(Description)

### Immunocompromised Patients
(Description)

### Others
(Description)

# Administration and Monitoring

### Administration
(Oral/Intravenous/etc)

### Monitoring
(Description regarding monitoring, from Warnings section)
(Description regarding monitoring, from Warnings section)
(Description regarding monitoring, from Warnings section)

# IV Compatibility
There is limited information regarding the compatibility of Glecaprevir / pibrentasvir and IV administrations.

# Overdosage

## Acute Overdose

### Signs and Symptoms
(Description)

### Management
(Description)

## Chronic Overdose

### Signs and Symptoms
(Description)

### Management
(Description)

# Pharmacology

## Mechanism of Action
(Description)

## Structure
(Description with picture)

## Pharmacodynamics
(Description)

## Pharmacokinetics
(Description)

## Nonclinical Toxicology
(Description)

# Clinical Studies
(Description)
(Description)
(Description)

# How Supplied
(Description)

## Storage
There is limited information regarding Glecaprevir / pibrentasvir Storage in the drug label.

# Images

## Drug Images

## Package and Label Display Panel

# Patient Counseling Information
(Patient Counseling Information)

# Precautions with Alcohol
Alcohol-Glecaprevir / pibrentasvir interaction has not been established. Talk to your doctor regarding the effects of taking alcohol with this medication.

# Brand Names
There is limited information regarding Glecaprevir / pibrentasvir Brand Names in the drug label.

# Look-Alike Drug Names
- (Paired Confused Name 1a)  (Paired Confused Name 1b)
- (Paired Confused Name 2a)  (Paired Confused Name 2b)
- (Paired Confused Name 3a)  (Paired Confused Name 3b)

# Drug Shortage Status
Drug Shortage

# Price